Univariate analysis | Multivariate analysis | |||
---|---|---|---|---|
Variables | Â | Hazard ratio (95%CI) | Hazard ratio (95%CI) | P value |
Gender | Male | 0.984 (0.521–1.857) | 1.132 (0.463–2.766) | 0.785 |
Age, Years | Age, years | 1.046 (1.025–1.068) | 1.045 (1.016–1.076) | 0.002 |
NYHA Class | Class IV | 1.549 (0.719–3.337) | 1.267 (0.527–3.046) | 0.597 |
Anemia | Yes | 1.483 (0.818–2.689) | 0.708 (0.333–1.504) | 0.369 |
Sodium, mEq/L |  | 0.933 (0.896–0.972) | 0.913 (0.851–0.980) | 0.011 |
Creatinine, mg/dl |  | 2.602 (2.052–3.300) | 1.966 (1.369–2.824) | <0.001 |
AF | Yes | 0.486 (0.225–1.051) | 0.617 (0.171–2.224) | 0.461 |
VHD | Yes | 0.636 (0.342–1.185) | 1.420 (0.413–4.886) | 0.578 |
IHD | Yes | 2.355 (1.182–4.691) | 2.211 (0.397–12.331) | 0.365 |
DCMP | Yes | 0.898 (0.352–2.290) | 1.068 (0.240–4.743) | 0.931 |
HHD | Yes | 1.036 (0.481–2.229) | 1.272 (0.338–4.794) | 0.722 |
LVEF |  | 0.997 (0.975–1.020) | 0.992 (0.958–1.027) | 0.634 |
Diuritics | Yes | 0.877 (0.269–2.858) | 0.690 (0.180–2.650) | 0.589 |
Spironolactone | Yes | 0.388 (0.214–0.703) | 0.343 (0.158–0.743) | 0.007 |
ACEI | Yes | 0.952 (0.510–1.778) | 0.258 (0.098–0.680) | 0.006 |
Beta Blocker | Yes | 1.205 (0.659–2.204) | 1.713 (0.766–3.832) | 0.190 |
Digoxin | Yes | 0.313 (0.132–0.746) | 0.407 (0.095–1.736) | 0.224 |
Antiplatelates | Yes | 0.883 (0.435–1.793) | 1.383 (0.352–5.436) | 0.643 |
Anticoagulants | Yes | 1.700 (0.817–3.541) | 2.429 (0.845–6.978) | 0.099 |
Statin | Yes | 1.520 (0.768–3.010) | 0.189 (0.037–0.972) | 0.046 |
CCB | Yes | 1.555 (0.720–3.359) | 0.815 (0.287–2.317) | 0.701 |